Randomized Controlled Multisite Trial of Injected Bulking Agents for Women With Intrinsic Sphincter Deficiency: Mid-urethral Injection of Zuidex Via the Implacer Versus Proximal Urethral Injection of Contigen Cystoscopically

Urology

Volumn 74, Issue 4, 2009, Pages 771-775

  Lightner, Deborah ^a   Rovner, Eric ^b   Corcos, Jacques ^c   Payne, Christopher ^d   Brubaker, Linda ^e   Drutz, Harold ^f   Steinhoff, Gary ^g  

^a MAYO CLINIC   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^e LOYOLA UNIVERSITY CHICAGO   (United States)

^f MOUNT SINAI HOSPITAL   (Canada)

^g Dr Steinhoff Clinical Research   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BULKING AGENT; COLLAGEN; DEXTRANOMER; GLUTARALDEHYDE CROSS LINKED COLLAGEN; UNCLASSIFIED DRUG; ZUIDEX;

ADULT; ARTICLE; BLADDER SPHINCTER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTOSCOPY; DRUG DELIVERY SYSTEM; DYSURIA; FEMALE; HUMAN; INJECTION SITE ABSCESS; INJECTION SITE MASS; INJECTION SITE PAIN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; PROVOCATION TEST; PSEUDOCYST; RANDOMIZED CONTROLLED TRIAL; STRESS INCONTINENCE; TREATMENT OUTCOME; URINARY TRACT INFECTION; URINARY URGENCY; URINE INCONTINENCE; URINE RETENTION; UROFLOWMETRY;

BIOCOMPATIBLE MATERIALS; COLLAGEN; CYSTOSCOPY; DEXTRANS; FEMALE; HUMANS; HYALURONIC ACID; INJECTIONS; MIDDLE AGED; PROSPECTIVE STUDIES; URETHRA; URINARY INCONTINENCE, STRESS;

EID: 70349446489     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.05.034     Document Type: Article

References (11)

1. Corcos J., Collet J.P., Shapiro S., et al. Multicenter randomized clinical trial comparing surgery and collagen injections for treatment of female stress urinary incontinence. Urology 65 (2005) 898-904
2. Stenberg A., Larsson G., Johnson P., et al. HA dextran copolymer, a new biocompatible material for endoscopic treatment of stress incontinent women. Short term results. Acta Obstet Gynecol Scand 78 (1999) 436-442
3. Stenberg A. Postmenopausal disorders with special reference to urinary incontinence. [Dissertation] (1998), Uppsala University, Sweden
4. Falk J., and Tollerz G. Chronic tissue response to implantation of Debrisan: an experimental study. Clin Ther 1 (1978) 185-191
5. Hahn I., and Fall M. Objective quantification of stress urinary incontinence: a short reproducible, provocative pad-test. Neurourol Urodyn 10 (1991) 475-481
6. van Kerrebroeck P., Ter Mulin F., Larsson G., et al. Efficacy and safety of a novel system (NASHA/Dx copolymer using the Implacer device) for the treatment of stress urinary incontinence. J Urol 64 (2004) 276-281
7. Administration USFaD. Draft guidance for preclinical and clinical investigations of urethral bulking agents used in the treatment of urinary incontinence. http://www.fda.gov/cdrh/ode/oderp850.html Accessed 1995
8. Lose G., Jorgensen L., and Thunedborg P. 24-Hour home pad weighing test versus 1-hour ward test in the assessment of mild stress incontinence. Acta Obstet Gynecol Scand 68 3 (1989) 211-215
9. Uebersax J.S., Wyman J.F., Shumaker S.A., et al. Short forms to assess life quality of life measures for women with urinary incontinence: the incontinence impact questionnaire and the urogenital distress inventory. Neurourol Urodyn 14 (1995) 131-139
10. Chapple C.R., Haab F., Cervigni M., et al. An Open & Multicenter Study of NASHA/Gel (Zuidex) for the treatment of stress urinary incontinence. Eur Urol 48 (2005) 488-494
11. Petrou S.P., Pak R.W., and Lightner D.J. Simple aspiration technique to address voiding dysfunction associated with transurethral injection of dextranomer/hyaluronic acid copolymer. Urology 68 (2006) 186-188